Abstract:Dysregulation of long noncoding RNAs (lncRNAs) has been regarded as a primary feature of several human cancers. However, the genome-wide expression and functional significance of lncRNAs in bladder cancer remains unclear. The aim of this study was to identify aberrantly expressed lncRNAs that may play an important role in contributing to bladder cancer pathogenesis. In this study, we described lncRNAs profiles in four pairs of human bladder cancer and matched normal bladder tissues by microarray. We finally determined 3,324 differentially expressed human lncRNAs and 2,120 differentially expressed mRNAs (>= 2-fold change). A total of 110 lncRNAs were significantly differentially expressed between the tumor and the control groups (>= 8-fold change). Four lncRNAs (TNXA, CTA-134P22.2, CTC-276P9.1 and KRT19P3) were selected for further confirmation of microarray results using quantitative PCR (qPCR), and a strong correlation was identified between the qPCR results and microarray data. We also observed that numerous lncRNA expression levels were significantly correlated with the expression of tens of protein coding genes by construction of the lncRNA-mRNA co-expression network. Kyoto Encyclopedia of Genes and Genomes annotation showed a significant association with p53, bladder cancer, cell cycle and propanoate metabolism pathway gene expression in the bladder cancer group compared with the normal tissue group, indicating that deregulated lncRNAs may act by regulating protein-coding genes in these pathways. We demonstrated the expression profiles of human lncRNAs in bladder cancer by microarray. We identified a collection of aberrantly expressed lncRNAs in bladder cancer compared with matched normal tissue. It is likely that these deregulated lncRNAs play a key or partial role in the development and/or progression of bladder cancer.

Gene expression profile changes in human bladder superficial transitional cell carcinoma

Monitoring gene expression profile changes in bladder transitional cell carcinoma using cDNA microarray.

Expressions of cyclooxygenase-2 and epidermal growth factor receptor in transitional cell carcinoma of bladder and their correlation

[Identification of Gene Expression Patterns in Superficial and Invasive Human Bladder Cancers].

Increased Cyclin-Dependent Kinase 6 Expression in Bladder Cancer

Upper urinary tract tumors developing after bladder transitional cell cancer

Altered γ-catenin expression in bladder transitional cell carcinoma and its implication

Differential Gene Expression Profiling in Aggressive Bladder Transitional Cell Carcinoma Compared to the Adjacent Microscopically Normal Urothelium by Microdissection-Smart Cdna PCR-SSH.

Gene expression profile and enrichment pathways in different stages of bladder cancer

Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder

Expression of octamer binding factor 4 in human transitional cell carcinoma tissue of bladder

Characterization of Genes Associated with Different Phenotypes of Human Bladder Cancer Cells

Study of Expression of Hmsh2 in Bladder Transitional Cell Carcinoma

Expression of PCNA in Human Bladder Transitional Cell Carcinoma and Its Clinical Significance

The expression analysis and its clinical significance of CST1 in bladder translational cell carcinoma

Expressions of P16 Protein and PCNA in Transitional Cell Carcinoma of the Urinary Bladder and Their Implications

Differential Expression of Ang-2 and HIF-1αand Their Significance in Transitional Cell Carcinoma of the Urinary Bladder

Proteome Analysis of Difference Between Human Bladder Low Grade Uroepithelium Cancer and Tumor-Adjacent Normal Bladder Tissue

[Differential Expression of Immune-Associated Genes in Two Subcloned Cell Lines from a Same Human Bladder Cancer].

Long Noncoding RNA Expression Signatures of Bladder Cancer Revealed by Microarray

The Expression and Clinical Significance of ZBTB7 in Transitional Cell Carcinoma of the Bladder.